DE3788738D1 - Dihydropyridine, Verfahren zu ihrer Herstellung und ihre Verwendung als Arzneimittel. - Google Patents

Dihydropyridine, Verfahren zu ihrer Herstellung und ihre Verwendung als Arzneimittel.

Info

Publication number
DE3788738D1
DE3788738D1 DE87301434T DE3788738T DE3788738D1 DE 3788738 D1 DE3788738 D1 DE 3788738D1 DE 87301434 T DE87301434 T DE 87301434T DE 3788738 T DE3788738 T DE 3788738T DE 3788738 D1 DE3788738 D1 DE 3788738D1
Authority
DE
Germany
Prior art keywords
sub
alkyl
group
straight
branched
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Fee Related
Application number
DE87301434T
Other languages
English (en)
Other versions
DE3788738T2 (de
Inventor
Claudio Semeraro
Dino Micheli
Daniele Pieraccioli
Giovanni Gaviraghi
Alan David Borthwick
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
GlaxoSmithKline SpA
Original Assignee
Glaxo SpA
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Glaxo SpA filed Critical Glaxo SpA
Publication of DE3788738D1 publication Critical patent/DE3788738D1/de
Application granted granted Critical
Publication of DE3788738T2 publication Critical patent/DE3788738T2/de
Anticipated expiration legal-status Critical
Expired - Fee Related legal-status Critical Current

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D211/00Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings
    • C07D211/04Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom
    • C07D211/80Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having two double bonds between ring members or between ring members and non-ring members
    • C07D211/84Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having two double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms, with at the most one bond to halogen directly attached to ring carbon atoms
    • C07D211/90Carbon atoms having three bonds to hetero atoms with at the most one bond to halogen
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00Drugs for disorders of the cardiovascular system
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00Drugs for disorders of the cardiovascular system
    • A61P9/10Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Medicinal Chemistry (AREA)
  • Veterinary Medicine (AREA)
  • Cardiology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Public Health (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Urology & Nephrology (AREA)
  • Vascular Medicine (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Hydrogenated Pyridines (AREA)
  • Plural Heterocyclic Compounds (AREA)
DE87301434T 1986-02-20 1987-02-19 Dihydropyridine, Verfahren zu ihrer Herstellung und ihre Verwendung als Arzneimittel. Expired - Fee Related DE3788738T2 (de)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
IT8619485A IT1204461B (it) 1986-02-20 1986-02-20 Derivati eterociclici

Publications (2)

Publication Number Publication Date
DE3788738D1 true DE3788738D1 (de) 1994-02-24
DE3788738T2 DE3788738T2 (de) 1994-04-28

Family

ID=11158424

Family Applications (1)

Application Number Title Priority Date Filing Date
DE87301434T Expired - Fee Related DE3788738T2 (de) 1986-02-20 1987-02-19 Dihydropyridine, Verfahren zu ihrer Herstellung und ihre Verwendung als Arzneimittel.

Country Status (7)

Country Link
US (1) US5051432A (de)
EP (1) EP0238211B1 (de)
JP (1) JPS62252782A (de)
AT (1) ATE100083T1 (de)
DE (1) DE3788738T2 (de)
IL (1) IL81565A (de)
IT (1) IT1204461B (de)

Families Citing this family (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20080089947A1 (en) * 2006-08-18 2008-04-17 Knox Clayton D Calcium Influx Inhibitors in the Treatment of Ischemia

Family Cites Families (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3455945A (en) * 1967-06-07 1969-07-15 Smithkline Corp 4-(carboxy (and carbo-lower alkoxy)phenyl)-1,4-dihydropyridines
JPS55301A (en) * 1978-02-14 1980-01-05 Yamanouchi Pharmaceut Co Ltd 1,4-dihydropyridine-3,5-dicarboxylic ester derivative and its preparation
DE2847236A1 (de) * 1978-10-31 1980-05-14 Bayer Ag Neue dihydropyridine mit substituierten estergruppierungen, mehrer verfahren zu ihrer herstellung sowie ihre verwendung als arzneimittel
JPS57171968A (en) * 1981-04-17 1982-10-22 Kyowa Hakko Kogyo Co Ltd 1,4-dihydropyridine derivative
NZ201395A (en) * 1981-07-30 1987-02-20 Bayer Ag Pharmaceutical compositions containing 1,4-dihydropyridines and certain of these dihydropyridines
DE3207982A1 (de) * 1982-03-05 1983-09-08 Bayer Ag, 5090 Leverkusen Neue 1,4-dihydropyridine, verfahren zu ihrer herstellung und ihrer verwendung in arzneimitteln
NZ212895A (en) * 1984-08-22 1988-07-28 Glaxo Spa 1,4-dihydropyridine derivatives and pharmaceutical compositions

Also Published As

Publication number Publication date
IT1204461B (it) 1989-03-01
US5051432A (en) 1991-09-24
IL81565A (en) 1991-09-16
EP0238211A3 (en) 1988-09-07
IT8619485A0 (it) 1986-02-20
EP0238211B1 (de) 1994-01-12
DE3788738T2 (de) 1994-04-28
JPS62252782A (ja) 1987-11-04
ATE100083T1 (de) 1994-01-15
EP0238211A2 (de) 1987-09-23

Similar Documents

Publication Publication Date Title
ES8703839A1 (es) Un procedimiento para la preparacion de esteres de acidos 1,4-dihidro-3,5-piridin-dicarbaxolicos.
DE69021502D1 (de) Benzimidazolderivate, Verfahren zu deren Herstellung und Anwendung.
DE19575012I2 (de) Carboxyalkyl-Dipeptide Verfahren zu ihrer Herstellung und diese enthaltende Arzneimittel
ATE18910T1 (de) Succinimid-derivate und verfahren zu ihrer herstellung.
DE69013607D1 (de) Pyrazol-Derivate, Verfahren zu deren Herstellung und Anwendung.
ATE15660T1 (de) Dihydropyridine als anti-ischaemische und antihypertensive mittel, verfahren zu ihrer herstellung und diese enthaltende pharmazeutische zusammensetzungen.
NO842987L (no) Fremgangsmaate ved fremstilling av 1-4 dihydropyridinderivater
ATE143020T1 (de) Aminocarbonylcarbamate verwandt mit physostigmin, verfahren zu ihrer herstellung und ihre verwendung als arzneimittel
NO972887L (no) Piperidineddiksyrederivater anvendelige som fibrinogen-antagonistmiddel
AT389108B (de) Neue pyridazinonderivate, verfahren zu ihrer herstellung und sie enthaltende pharmazeutische zusammensetzungen
ES2061966T3 (es) Mejoras introducidas en la sintesis de derivados 6-metilenicos de androsta-1,4-dieno-3,17-diona.
DE69200284D1 (de) Verwendung von 4-(3-trifluormethylphenyl)-1,2,3,6-Tetrahydropyridinderivaten als freie Radikalfänger.
DE3864707D1 (de) Benzoxazin-derivate und verfahren zu ihrer herstellung.
DE3788738D1 (de) Dihydropyridine, Verfahren zu ihrer Herstellung und ihre Verwendung als Arzneimittel.
ATE88997T1 (de) 1,4-dihydropyridinderivate.
ES2016017A6 (es) Procedimiento para preparar derivados de acido 1,1-dioxocefem-4-carbotiolico.
OA08508A (fr) Dérivés dissymétriques de l'acide 1,4-dihydropyridine-3,5-dicarboxylique, procédés de préparation et utilisation en thérapeutique.
DK162982C (da) 1,4-dihydropyridinderivater og farmaceutiske praeparater indeholdende disse
DE3779813D1 (en) 1,4-dihydropyridinderivate.
ES2012687A6 (es) Procedimiento de preparacion de derivados 1,4-dihidro-piridinas.
DE3785963D1 (de) Dihydropyridine, verfahren zu ihrer herstellung und ihre verwendung als arzneimittel.
DE69125569D1 (de) 8-Azabicyclo[3.2.1]octylalkylthiazolidinone, Verfahren zu ihrer Herstellung und ihre Verwendung als Arzneimittel
ATE42291T1 (de) Spiro(indolo(1,7-ab>(1,5>benzodiazepin-2,4'piperidine> und zwischenprodukte, verfahren zu ihrer herstellung und ihre anwendung als arzneimittel.
FI870695A (fi) Heterocykliska foereningar och deras framstaellning och farmaceutiskt preparat.
JO1452B1 (en) Heterocyclic derivatives

Legal Events

Date Code Title Description
8364 No opposition during term of opposition
8339 Ceased/non-payment of the annual fee